Back
BNY Mellon Ultra Short Income ETF Vs. Novartis AG Industry Stock Comparison
Sell
38
BKUI
BNY Mellon Ultra Short Income ETF
Last Price:
$49.86
Seasonality Move:
0.14%
Buy
71
NVSEF
Novartis AG
Last Price:
$130.78
Seasonality Move:
-4.44%
Sell
38
BNY Mellon Ultra Short Income ETF (BKUI)
is a Sell
Is BNY Mellon Ultra Short Income ETF a Buy, Sell or Hold?
-
The current BNY Mellon Ultra Short Income ETF [BKUI] share price is $49.85. The Score for BKUI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
BKUI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $138.80. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BKUI Stock Price Chart
What is BNY Mellon Ultra Short Income ETF's stock price today?
-
The BNY Mellon Ultra Short Income ETF share price today is $49.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BKUI is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $138.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
BKUI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 55.1 | Buy |
| Chaikin Money Flow: | -3311 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.79 - 49.87) | Buy |
| Bollinger Bands (100): | (49.78 - 49.9) | Buy |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 69.21 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BKUI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.82 | Buy |
| 20-day SMA: | 49.84 | Buy |
| 50-day SMA: | 49.85 | Buy |
| 200-day SMA: | 49.79 | Buy |
| 8-day EMA: | 49.83 | Buy |
| 20-day EMA: | 49.83 | Buy |
| 50-day EMA: | 49.84 | Buy |
| 200-day EMA: | 49.79 | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.44 | Buy |
| 20-day SMA: | 127.9 | Buy |
| 50-day SMA: | 128.04 | Buy |
| 200-day SMA: | 119.05 | Buy |
| 8-day EMA: | 129.81 | Buy |
| 20-day EMA: | 128.39 | Buy |
| 50-day EMA: | 127.3 | Buy |
| 200-day EMA: | 120.27 | Buy |
BNY Mellon Ultra Short Income ETF Earnings Growth & BKUI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BNY Mellon Ultra Short Income ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||